PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1627983
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1627983
Joint Reconstruction Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
The Global Joint Reconstruction Devices Market reached USD 19.6 billion in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2032. This growth is fueled by the increasing prevalence of joint disorders and injuries worldwide. Factors such as the aging population and the rise in joint-related conditions like osteoarthritis and rheumatoid arthritis drive demand for reconstructive procedures. Additionally, an uptick in sports-related injuries among younger demographics, fueled by the growing popularity of fitness and athletic activities, has further boosted the market.
Technological innovations are transforming the landscape of joint reconstruction devices. Advances in biocompatible materials, 3D printing, and implant design are enhancing the durability and functionality of devices, leading to better surgical outcomes and patient satisfaction. These developments are expanding the appeal of joint reconstruction surgeries across diverse age groups.
The market is segmented by joint type into knee, hip, shoulder, ankle replacements, and other products. The knee replacement segment is poised to grow at a CAGR of 5.1%, surpassing USD 14.5 billion by 2032. High demand in this segment stems from the widespread prevalence of knee-related conditions that impair mobility and quality of life, particularly among the elderly. Knee replacements remain the preferred joint reconstruction surgeries, driven by the increasing need for surgical interventions to address progressive joint damage.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $19.6 Billion |
| Forecast Value | $29.1 Billion |
| CAGR | 4.5% |
By end use, the market is categorized into hospitals & clinics, ambulatory centers, and others. Hospitals and clinics dominated the segment in 2023, projected to reach USD 20.7 billion by 2032. These facilities are preferred for joint reconstruction surgeries due to their ability to manage complex cases with advanced tools, robotic systems, and cutting-edge imaging technologies. Their comprehensive resources enable precise and efficient procedures, especially for major joint surgeries.
North America accounted for USD 10.5 billion in market revenue in 2023 and is set to grow at a CAGR of 3.4% from 2024 to 2032. The region's market expansion is primarily driven by the aging population, leading to a rise in joint conditions like osteoarthritis and osteoporosis. Lifestyle factors, including high obesity rates and sedentary habits, are also contributing to joint degeneration, increasing the demand for reconstruction procedures. Robust healthcare infrastructure and technological adoption further support market growth in North America.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Growing base of geriatric population
- 3.2.1.2 Increasing prevalence of orthopedic diseases
- 3.2.1.3 Technological advancements
- 3.2.1.4 Growing rate of joint reconstruction surgeries
- 3.2.1.5 Need for personalized and patient specific implants
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High cost of the devices
- 3.2.2.2 Stringent FDA regulations
- 3.2.2.3 Post-surgical complications
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Technology landscape
- 3.5 Supply chain analysis
- 3.6 Future market trends
- 3.7 Regulatory landscape
- 3.8 Reimbursement scenario
- 3.9 Investment overview
- 3.10 Porter's analysis
- 3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Joint Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Knee replacement
- 5.2.1 By product
- 5.2.1.1 Primary knee systems
- 5.2.1.2 Partial knee systems
- 5.2.1.3 Revision knee systems
- 5.2.2 By component
- 5.2.2.1 Femoral component
- 5.2.2.2 Tibial component
- 5.2.2.3 Patellar component
- 5.2.1 By product
- 5.3 Hip Replacement
- 5.3.1 By product
- 5.3.1.1 Primary hip reconstruction devices
- 5.3.1.2 Revision hip reconstruction devices
- 5.3.1.3 Partial hip reconstruction devices
- 5.3.1.4 Hip resurfacing devices
- 5.3.2 By component
- 5.3.2.1 Acetabular component
- 5.3.2.2 Femoral component
- 5.3.1 By product
- 5.4 Shoulder Replacement
- 5.4.1 Shoulder arthroplasty resurfacing implants
- 5.4.2 Shoulder arthroplasty trauma implants
- 5.4.3 Shoulder arthroplasty platform implants
- 5.5 Ankle Replacement
- 5.5.1 Two-component fixed bearing
- 5.5.2 Three-component mobile bearing
- 5.6 Other joint types
Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Hospitals & clinics
- 6.3 ASCs
- 6.4 Other end users
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.6 Middle East and Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
Chapter 8 Company Profiles
- 8.1 Aesculap Implant Systems
- 8.2 Allegra Orthopedic
- 8.3 Amplitude Ortho
- 8.4 Arthrex
- 8.5 CONMED
- 8.6 DJO Global
- 8.7 Exactech
- 8.8 Globus Medical
- 8.9 Integra LifeSciences
- 8.10 Johnson & Johnson
- 8.11 Medacta International
- 8.12 Microport
- 8.13 NuVasive
- 8.14 Smith & Nephew
- 8.15 Stryker
- 8.16 Zimmer Biomet
